0001723128-19-000088.txt : 20190509
0001723128-19-000088.hdr.sgml : 20190509
20190509174325
ACCESSION NUMBER: 0001723128-19-000088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190507
FILED AS OF DATE: 20190509
DATE AS OF CHANGE: 20190509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stewart Robert A
CENTRAL INDEX KEY: 0001476493
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 19812009
MAIL ADDRESS:
STREET 1: 360 MT. KEMBLE AVENUE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
wf-form4_155743819080725.xml
FORM 4
X0306
4
2019-05-07
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001476493
Stewart Robert A
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD, 3RD FLOOR
BRIDGEWATER
NJ
08807
1
1
0
0
President and CEO
Class A Common Stock
2019-05-07
4
M
0
83277
A
100277
D
Class A Common Stock
2019-05-07
4
F
0
21609
13.44
D
78668
D
Restricted Stock Units
2019-05-07
4
M
0
83277
0
D
Class A Common Stock
83277.0
249834
D
Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
On May 7, 2018, the reporting person was granted 333,111 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.
/s/ Brian P. Spitser, Attorney-in-Fact
2019-05-09